Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
EMD Serono
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
Gomekli
(mirdametinib) / EMD Serono
berzosertib
(M6620) / EMD Serono
tuvusertib
(M1774) / EMD Serono
peposertib
(M3814) / EMD Serono
pimasertib
(AS703026) / Day One Biopharma
maveropepimut-S
(MVP-S) / BioVaxys
JZP150
/ Jazz
PDS01ADC
/ PDS Biotech
M9466
/ EMD Serono
TL895
/ Telios Pharma
abituzumab
(EMD 525797) / EMD Serono, SFJ Pharma
itareparib
(NMS-293) / Nerviano Medical Sciences
matuzumab
(EMD 72000) / Takeda, EMD Serono
sprifermin
(AS-902330) / Formation Bio
QUC398
/ Novartis
precemtabart tocentecan
(M9140) / EMD Serono
Orzel
(UFT + Leucovorin) / EMD Serono, Otsuka
Tcelna
(imilecleucel-T) / EMD Serono, Zevra Therap
cabamiquine
(M5717) / EMD Serono
lartesertib
(M4076) / EMD Serono
DI Leu16 IL-2
/ Provenance, Alopexx
Selectikine
(EMD 521873) / EMD Serono
brimarefenib
(BGB-3245) / MapKure, EMD Serono
dargistotug
(M6223) / EMD Serono
gartisertib
(M4344) / EMD Serono
plovamer
(CO-14) / EMD Serono
EMD55900
/ EMD Serono
ompenaclid
(RGX-202) / Inspirna, EMD Serono
PEG-somatropin
(ARX201) / EMD Serono, J&J
atexakin alfa
(recombinant interleukin-6) / Sonnet BioTherap
compound 121564
/ EMD Serono
